AbbVie Inc.
Single-Chain Trail-Receptor Agonist Proteins
Last updated:
Abstract:
Provided herein are specific TRAIL receptor agonist proteins, nucleic acids encoding the same, and methods of treating a subject having a TRAIL-associated disease or disorder. The TRAIL receptor agonist proteins provided herein comprise three soluble TRAIL domains and an Fc fragment. The TRAIL receptor agonist proteins are substantially non-aggregating and suitable for therapeutic, diagnostic and/or research applications.
Status:
Application
Type:
Utility
Filling date:
14 Aug 2020
Issue date:
11 Feb 2021